The changing epidemiology of Burkholderia species infection at an adult cystic fibrosis centre

Journal of Cystic Fibrosis

Volumn 7, Issue 5, 2008, Pages 368-372

  France, Megan W ^a   Dodd, Mary E ^a   Govan, John R ^b   Doherty, Catherine J ^b   Webb, A K ^a   Jones, Andrew M ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Burkholderia cepacia complex; Epidemiology; Infection control

Indexed keywords

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BURKHOLDERIA; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; EPIDEMIOLOGICAL DATA; HEALTH CARE FACILITY; HUMAN; INCIDENCE; INFECTION CONTROL; PATIENT CARE; PATIENT REFERRAL; PATIENT TRANSPORT; POLYMERASE CHAIN REACTION; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; RESPIRATORY TRACT INFECTION; SPECIES DIFFERENCE; UNITED KINGDOM;

BACTERIAL TYPING TECHNIQUES; BURKHOLDERIA; BURKHOLDERIA INFECTIONS; CROSS INFECTION; CYSTIC FIBROSIS; ENGLAND; EPIDEMIOLOGY, MOLECULAR; HUMANS; INCIDENCE; INFECTION CONTROL; PREVALENCE; PROSPECTIVE STUDIES; SPUTUM;

EID: 41749124390     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2008.01.002     Document Type: Article

References (33)

1. Coenye T., Vandamme P., Govan J.R., and LiPuma J.J. Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol 39 10 (2001 Oct) 3427-3436
2. Isles A., Maclusky I., Corey M., Gold R., Prober C., Fleming P., et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 104 2 (1984 Feb) 206-210
3. Yabuuchi E., Kosako Y., Oyaizu H., Yano I., Hotta H., Hashimoto Y., et al. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol 36 12 (1992) 1251-1275 5
4. Vandamme P., Holmes B., Vancanneyt M., Coenye T., Hoste B., Coopman R., et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol 47 4 (1997 Oct) 1188-1200
5. Vandamme P., Govan J., and LiPuma J. Diversity and role of Burkholderia spp. In: Vandamme P., and Coenye T. (Eds). Burkholderia: molecular biology and genomics (2007), Horizon Press
6. LiPuma J.J., Dasen S.E., Nielson D.W., Stern R.C., and Stull T.L. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336 8723 (1990 Nov 3) 1094-1096
7. Govan J.R., Brown P.H., Maddison J., Doherty C.J., Nelson J.W., Dodd M., et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342 8862 (1993 Jul 3) 15-19
8. Biddick R., Spilker T., Martin A., and LiPuma J.J. Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis. FEMS Microbiol Lett 228 1 (2003 Nov 7) 57-62
9. Saiman L., and Siegel J. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol 24 5 Suppl (2003 May) S6-S52
10. Garred P., Pressler T., Madsen H.O., Frederiksen B., Svejgaard A., Hoiby N., et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 104 4 (1999 Aug) 431-437
11. Davies J., Neth O., Alton E., Klein N., and Turner M. Differential binding of mannose-binding lectin to respiratory pathogens in cystic fibrosis. Lancet 355 9218 (2000 May 27) 1885-1886
12. Pankhurst C.L., and Philpott-Howard J. The environmental risk factors associated with medical and dental equipment in the transmission of Burkholderia (Pseudomonas) cepacia in cystic fibrosis patients. J Hosp Infect 32 4 (1996 Apr) 249-255
13. Ensor E., Humphreys H., Peckham D., Webster C., and Knox A.J. Is Burkholderia (Pseudomonas) cepacia disseminated from cystic fibrosis patients during physiotherapy?. J Hosp Infect 32 1 (1996 Jan) 9-15
14. Ledson M.J., Gallagher M.J., Corkill J.E., Hart C.A., and Walshaw M.J. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax 53 5 (1998 May) 432-436
15. Mahenthiralingam E., Vandamme P., Campbell M.E., Henry D.A., Gravelle A.M., Wong L.T., et al. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis 33 9 (2001 Nov 1) 1469-1475
16. Frangolias D.D., Mahenthiralingam E., Rae S., Raboud J.M., Davidson A.G., Wittmann R., et al. Burkholderia cepacia in cystic fibrosis. Variable disease course. Am J Respir Crit Care Med 160 5 Pt 1 (1999 Nov) 1572-1577
17. Ledson M.J., Gallagher M.J., Jackson M., Hart C.A., and Walshaw M.J. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 57 2 (2002 Feb) 142-145
18. Courtney J.M., Dunbar K.E., McDowell A., Moore J.E., Warke T.J., Stevenson M., et al. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults. Cyst Fibros 3 2 (2004 Jun) 93-98
19. Jones A.M., Dodd M.E., Govan J.R., Barcus V., Doherty C.J., Morris J., et al. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax 59 11 (2004 Nov) 948-951
20. Taccetti G., Costantini D., and Furnari M.L. Clinical follow-up of 122 Italian cystic fibrosis patients with B. cepacia complex colonisation. Cyst Fibros 4 2 (2005 May) 145-146 author reply 7
21. Tablan O.C., Chorba T.L., Schidlow D.V., White J.W., Hardy K.A., Gilligan P.H., et al. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 107 3 (1985 Sep) 382-387
22. Jones A.M., and Webb A.K. Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp. J R Soc Med 96 Suppl 43 (2003) 66-72
23. Blackburn L., Brownlee K., Conway S., and Denton M. 'Cepacia syndrome' with Burkholderia multivorans, 9 years after initial colonization. Cyst Fibros 3 2 (2004 Jun) 133-134
24. Chaparro C., Maurer J., Gutierrez C., Krajden M., Chan C., Winton T., et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 163 1 (2001 Jan) 43-48
25. De Soyza A., McDowell A., Archer L., Dark J.H., Elborn S.J., Mahenthiralingam E., et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 358 9295 (2001 Nov 24) 1780-1781
26. Aris R.M., Routh J.C., LiPuma J.J., Heath D.G., and Gilligan P.H. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 164 11 (2001 Dec 1) 2102-2106
27. The Burkholderia cepacia complex - suggestions for prevention and infection control. London, UK: CF Trust UK (2004)
28. Coenye T., Spilker T., Van Schoor A., LiPuma J.J., and Vandamme P. Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe. Thorax 59 11 (2004 Nov) 952-954
29. Vonberg R.P., and Gastmeier P. Isolation of infectious cystic fibrosis patients: results of a systematic review. Infect Control Hosp Epidemiol 26 4 (2005 Apr) 401-409
30. Festini F., Buzzetti R., Bassi C., Braggion C., Salvatore D., Taccetti G., et al. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review. J Hosp Infect 64 1 (2006 Sep) 1-6
31. Frederiksen B., Koch C., and Hoiby N. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 28 3 (1999 Sep) 159-166
32. Hoiby N., and Johansen H.K. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review?. J Hosp Infect (2007 Feb 1)
33. Jones A.M., Dodd M.E., and Webb A.K. Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas. Eur Respir J 17 2 (2001 Feb) 295-301